# Study to Assess the Absorption and Tolerability of Intranasal Ketorolac Tromethamine and to Assess the Effects of Oxymetazoline Hydrochloride and Fluticasone Propionate on the Absorption and Tolerability of Intranasal Ketorolac Tromethamine in Participants With Allergic Rhinitis

> **NCT01365650** · PHASE1 · COMPLETED · sponsor: **Egalet Ltd** · enrollment: 24 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Ketorolac Tromethamine
- **DRUG:** Oxymetazoline Hydrochloride
- **DRUG:** Fluticasone Propionate

## Key facts

- **NCT ID:** NCT01365650
- **Lead sponsor:** Egalet Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-02
- **Final completion:** 2008-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01365650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01365650, "Study to Assess the Absorption and Tolerability of Intranasal Ketorolac Tromethamine and to Assess the Effects of Oxymetazoline Hydrochloride and Fluticasone Propionate on the Absorption and Tolerability of Intranasal Ketorolac Tromethamine in Participants With Allergic Rhinitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01365650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*